ProPhase Labs, Inc. (PRPH) Social Stream



ProPhase Labs, Inc. (PRPH): $7.60

0.57 (+8.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 507

in industry

ProPhase Labs Inc (PRPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PRPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 1 $5 $5 $5 $8.13 -38.5%
2021-12-20 2 $12 $5 $8.5 $8.13 4.55%
2022-02-16 2 $15 $5 $10 $8.13 23%
2022-03-31 2 $16 $5 $10.5 $8.13 29.15%

The Trend in the Analyst Price Target


Over the past 175 months, PRPH's average price target has gone up $2.5.

PRPH reports an average of 185.76% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 0 25 20 22.5 5.23 330.21%
2021-05-22 0 25 20 22.5 6.37 253.22%
2021-08-05 0 25 20 22.5 7.31 207.8%
2021-09-11 0 20 9 14.5 5.66 156.18%
2022-01-14 2 15 5 10.0 7.30 36.99%

PRPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 28 days, PRPH's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ProPhase Labs Inc's number of analysts covering the stock is greater than 18.84% of all US stocks.
  • PRPH has a lower variance in analysts' estimates than -172.29% of all US stocks.
  • In terms of how ProPhase Labs Inc fares relative to all US stocks, note that its average analyst price target is greater than 30.55% of that group.
  • In terms of how ProPhase Labs Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 32.33% of that group.

In the Pharmaceutical Products industry, PHIO, PCSA, and ORGS are the three stocks most similar to ProPhase Labs Inc regarding the price target and analyst recommendation information presented here.

Is PRPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1072 seconds.